Mario Jesus Marte director
Shares sold: 7 Price: $101.13
Date: Mar. 1 Directly holds: na
patrick GOepel director
Shares sold: 1,166 Price: $32
Date: Feb. 26 Directly holds: 72,554
Michael M. Selzer JR. director
Exercised options: 4,000 Price: $16.97
Date: Mar. 2 Directly holds: na
Willard D. Oberton director
Exercised options: 4,400 Price: $34.21
Shares sold: 4,400 Price: $60.20
Date: Mar. 1 Directly holds: 22,196
Glenn R. Leitch officer
Exercised options: 140,000 Price: $15.49
Shares sold: 140,000 Price: $47.22
Date: Feb. 25 Directly holds: 127,952
Lori Marco general counsel
Shares purchased: 239 Price: $46.84
Date: Mar. 2 Indirectly holds: 34,611
James N. Sheehan CFO
Exercised options: 32,400 Price: $22.99
Shares sold: 32,400 Price: $46.94
Date: Feb. 26 Directly holds: 180,611
Michael P. Geraci officer
Exercised options: 15,000 Price: $4.53
Date: Mar. 1 Directly holds: na
Hoedt Rob Ten officer
Exercised options: 7,168 Price: $34.88 Shares sold: 7,168 Price: $117.98
Date: Mar. 2 Directly holds: 43,797
Dougherty lucy Clark general counsel
Shares sold: 5,781 Price: $125
Date: Feb. 24 Directly holds: 25,330
Michael D. Dougherty officer
Exercised options: 19,000 Price: $70.18
Shares sold: 19,000 Price: $125
Date: Feb. 24 Directly holds: 60,667
John B. goodman director
Shares sold: 1,000 Price: $151.19
Date: Mar. 1 Directly holds: 12,586
Samuel R. Hellfeld officer
Shares sold: 3,782 Price: $146
Date: Mar. 2 Directly holds: 8,989
Shelly Radue Ibach CEO
Exercised options: 10,000 Price: $18.81
Shares sold: 10,000 Price: $145.22
Date: Mar. 2 Directly holds: 170,433
Kathleen L. Nedorostek director
Exercised options: 7,370 Price: Date: Feb. 25 $17.34-$30.50
Shares sold: 7,370 Price: $138.01-$138.42
Date: Feb. 26 Directly holds: 15,996
Robert Joseph Poirier officer
Exercised options: 1,636 Price: $23.61-$47 Shares sold: 1,636 Price: $143.09
Date: Mar. 1 Directly holds: 1,168
James J. Frome COO
Exercised options: 44,470 Price:
Date: Feb. 26 $27.37-$54.54
Shares sold: 66,406 Price: $99.58-$103.71
Date: Feb. 26-Mar. 1 Directly holds: 39,299
Kimberly K. Nelson CFO
Shares sold: 8,005 $104.17-$106.31
Date: Feb. 25 Directly holds: 124,902
James Burr Ramsey director
Exercised options: 17,422 Price:
$25.51-$25.87
Exercised options: 17,422 Price:
$25.51-$25.87
Shares sold: 17,422 $103.40-$106.12
Date: Feb. 24 Directly holds: 11,904
Timothy J. Arens CFO
Exercised options: 10,973 Price:
Date: Feb. 24 $20.25-$21.03
Directly holds: na
JosE H. Bedoya director
Shares sold: 1,497 Price: $50.68
Date: Feb. 23 Directly holds: 22,817
Susan E. Knight officer
Exercised options: 5,576 Price: $21.31
Shares sold: 5,576 Price: $52.36
Date: Feb. 26 Directly holds: 28,714
Gary R. Maharaj CEO
Shares sold: 4,000 Price: $51.86-$52.67
Date: Mar. 1 Directly holds: 164,713
Charles W. olson officer
Exercised options: 13,533 Price:
Date: Feb. 26 $20.25-$21.03
Directly holds: na
Brent Moen CFO
Shares sold: 1,429 Price: $50.91
Date: Feb. 26 Directly holds: 25,865
Bryan F. Rishe officer
Shares sold: 1,062 Price: $50.90
Date: Feb. 26 Directly holds: 37,763
Thomas E. Roos officer
Shares sold: 423 Price: $334.36
Date: Mar. 1 Directly holds: 32,424
The proposed agreement would settle lawsuits from patients in 2019 who were seeking a new and costly form of radiation therapy.
